AU, K., Y, S., CC, P., P, S., MR, S., S, C., . . . DE, S. (2026). Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: An individual patient data meta-analysis. Lancet (London, England), 407(10533), 1059. https://doi.org/10.1016/S0140-6736(26)00137-6
Chicago Style (17th ed.) CitationAU, Kishan, et al. "Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis." Lancet (London, England) 407, no. 10533 (2026): 1059. https://doi.org/10.1016/S0140-6736(26)00137-6.
MLA (9th ed.) CitationAU, Kishan, et al. "Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis." Lancet (London, England), vol. 407, no. 10533, 2026, p. 1059, https://doi.org/10.1016/S0140-6736(26)00137-6.